|
SELO expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.113800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.926200E-01 |
| Normal-vs-Stage2 |
8.661600E-01 |
| Normal-vs-Stage3 |
6.860800E-01 |
| Normal-vs-Stage4 |
3.956600E-01 |
| Stage1-vs-Stage2 |
8.999000E-01 |
| Stage1-vs-Stage3 |
9.210800E-01 |
| Stage1-vs-Stage4 |
5.383000E-01 |
| Stage2-vs-Stage3 |
8.647200E-01 |
| Stage2-vs-Stage4 |
5.684800E-01 |
| Stage3-vs-Stage4 |
6.634600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.318770E-01 |
| Normal-vs-AfricanAmerican |
3.75670000000161E-05 |
| Normal-vs-Asian |
2.118400E-01 |
| Caucasian-vs-AfricanAmerican |
9.90770000486307E-08 |
| Caucasian-vs-Asian |
1.218470E-02 |
| AfricanAmerican-vs-Asian |
6.811800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.515000E-01 |
| Normal-vs-Female |
1.910610E-01 |
| Male-vs-Female |
4.220700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.534400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.487600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.013000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.770600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.760800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.341200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.993600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.205000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.479200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.742600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.401770E-02 |
| Normal-vs-Grade 2 |
5.978600E-01 |
| Normal-vs-Grade 3 |
4.562800E-01 |
| Normal-vs-Grade 4 |
6.833000E-01 |
| Grade 1-vs-Grade 2 |
1.833920E-02 |
| Grade 1-vs-Grade 3 |
6.975600E-03 |
| Grade 1-vs-Grade 4 |
3.174100E-02 |
| Grade 2-vs-Grade 3 |
7.478600E-01 |
| Grade 2-vs-Grade 4 |
9.892600E-01 |
| Grade 3-vs-Grade 4 |
8.270600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.707810E-01 |
| Normal-vs-ccB subtype |
4.761500E-02 |
| ccA subtype-vs-ccB subtype |
2.891800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.168800E-01 |
| Normal-vs-N1 |
6.323600E-01 |
| N0-vs-N1 |
3.699600E-01 |
|
|
